Time-in-therapeutic-range defined warfarin and standard dose direct oral anticoagulants in atrial fibrillation: Ischemic stroke, intracranial hemorrhage and death in a nationwide registry study

被引：0
|
作者：
Lehto, M. [1 ]
Luojus, A. [1 ]
Halminen, O. [2 ]
Haukka, J. [3 ]
Lehtonen, O. [2 ]
Tiili, P.
Aro, A. L. [1 ]
Putaala, J. [1 ]
Linna, M. [4 ]
Mustonen, P. [5 ]
Kinnunen, J. [1 ]
Niemi, M.
Hartikainen, J. [6 ]
Airaksinen, K. E. J.
机构：
[1] Helsinki Univ Hosp, Helsinki, Finland
[2] Aalto Univ, Espoo, Finland
[3] Univ Helsinki, Helsinki, Finland
[4] Univ Eastern Finland, Kuopio, Finland
[5] Turku Univ Hosp, Turku, Finland
[6] Kuopio Univ Hosp, Kuopio, Finland
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Use of oral anticoagulants and its associated factors among nonvalvular atrial fibrillation patients with new-onset acute ischemic stroke: A report from the China Atrial Fibrillation Registry study
    Wang, Jing-Rong
    Du, Xin
    Dong, Jian-Zeng
    Chang, San-Shuai
    Jiang, Chao
    Sang, Cai-Hua
    Long, De-Yong
    Tang, Ri-Bo
    Zhang, Hai-Bin
    Guo, Jin-Cheng
    Wen, Yu-Mei
    He, Liu
    Ma, Chang-Sheng
    CLINICAL CARDIOLOGY, 2022, 45 (01) : 60 - 67
  • [32] Fiix-prothrombin time monitoring improves warfarin anticoagulation outcome in atrial fibrillation: a systematic review of randomized trials comparing Fiix-warfarin or direct oral anticoagulants to standard PT-warfarin
    Onundarson, P. T.
    Arnar, D. O.
    Lund, S. H.
    Gudmundsdottir, B. R.
    Francis, C. W.
    Indridason, O. S.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2016, 38 : 78 - 90
  • [33] Impact of Reduced-Dose Nonvitamin K Antagonist Oral Anticoagulants on Outcomes Compared to Warfarin in Korean Patients with Atrial Fibrillation: A Nationwide Population-Based Study
    Han, Sola
    Kim, Young-Hoon
    Lee, Myung-Yong
    Bang, Oh Young
    Jang, Sung-Won
    Han, Seongwook
    Park, Yoo-Jung
    Kang, Seongsik
    On, Young Keun
    Suh, Hae Sun
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (17)
  • [34] Clinical Effectiveness of Direct Oral Anticoagulants vs Warfarin in Older Patients With Atrial Fibrillation and Ischemic Stroke Findings From the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study
    Xian, Ying
    Xu, Haolin
    O'Brien, Emily C.
    Shah, Shreyansh
    Thomas, Laine
    Pencina, Michael J.
    Fonarow, Gregg C.
    Olson, DaiWai M.
    Schwamm, Lee H.
    Bhatt, Deepak L.
    Smith, Eric E.
    Hannah, Deidre
    Maisch, Lesley
    Lytle, Barbara L.
    Peterson, Eric D.
    Hernandez, Adrian F.
    JAMA NEUROLOGY, 2019, 76 (10) : 1192 - 1202
  • [35] Short-term risk of bleeding, ischemic stroke, and death in patients with atrial fibrillation switching between oral anticoagulants: A case-crossover study
    Hellfritzsch, Maja
    Wang, Shirley V.
    Grove, Erik L.
    Gagne, Joshua J.
    Hallas, Jesper
    Pottegard, Anton
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 201 - 202
  • [36] Intracranial Hemorrhage Among Patients With Atrial Fibrillation Anticoagulated With Warfarin or Rivaroxaban The Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation
    Hankey, Graeme J.
    Stevens, Susanna R.
    Piccini, Jonathan P.
    Lokhnygina, Yuliya
    Mahaffey, Kenneth W.
    Halperin, Jonathan L.
    Patel, Manesh R.
    Breithardt, Guenter
    Singer, Daniel E.
    Becker, Richard C.
    Berkowitz, Scott D.
    Paolini, John F.
    Nessel, Christopher C.
    Hacke, Werner
    Fox, Keith A. A.
    Califf, Robert M.
    STROKE, 2014, 45 (05) : 1304 - 1312
  • [37] Switching from vitamin K antagonists to direct oral anticoagulants in non-valvular atrial fibrillation patients: Does low time in therapeutic range affect persistence?
    Toorop, Myrthe M. A.
    Chen, Qingui
    Kruip, Marieke J. H. A.
    van der Meer, Felix J. M.
    Nierman, Melchior C.
    Faber, Laura
    Goede, Lies
    Cannegieter, Suzanne C.
    Lijfering, Willem M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (02) : 339 - 352
  • [38] Concurrent use of statins decreases major bleeding and intracerebral hemorrhage in non-valvular atrial fibrillation patients taking direct oral anticoagulants-A nationwide cohort study
    Wu, Hsin-Hsu
    Chang, Shang-Hung
    Lee, Tsong-Hai
    Tu, Hui-Tzu
    Liu, Chi-Hung
    Chang, Ting-Yu
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [39] Clinical Effectiveness of Direct Oral Anticoagulants (DOACs) vs. Warfarin in Older Ischemic Stroke Patients With Atrial Fibrillation: Findings From Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study.
    Xian, Ying
    Xu Haolin
    O'Brien, Emily G.
    Shah, Shreyansh
    Thomas, Laine
    Pencina, Michael J.
    Fonarow, Gregg C.
    Olson, DaiWai M.
    Schwamm, Lee H.
    Bhatt, Deepak L.
    Smith, Eric E.
    Hannah, Deidre
    Lindholm, Brianna
    Maisch, Lesley
    Lytle, Barbara L.
    Peterson, Eric D.
    Hernandez, Adrian F.
    STROKE, 2019, 50
  • [40] Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage
    Tsai, Chuan-Tsai
    Liao, Jo-Nan
    Chiang, Chern-En
    Lin, Yenn-Jiang
    Chang, Shih-Lin
    Lo, Li-Wei
    Hu, Yu-Feng
    Tuan, Ta-Chuan
    Chung, Fa-Po
    Chao, Tze-Fan
    Lip, Gregory Y. H.
    Chen, Shih-Ann
    JAMA NETWORK OPEN, 2020, 3 (06) : E206424
12345